1/2
05:01 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Jan 01 Filed by: Levin Rami
Low
Report
Form 4 CNS Pharmaceuticals, For: Jan 01 Filed by: Levin Rami
1/2
05:00 pm
cnsp
Form 3 CNS Pharmaceuticals, For: Jan 01 Filed by: Levin Rami
Low
Report
Form 3 CNS Pharmaceuticals, For: Jan 01 Filed by: Levin Rami
12/17
08:44 am
cnsp
Form 8-K CNS Pharmaceuticals, For: Dec 16
Medium
Report
Form 8-K CNS Pharmaceuticals, For: Dec 16
11/21
05:19 pm
cnsp
Form 8-K CNS Pharmaceuticals, For: Nov 17
Low
Report
Form 8-K CNS Pharmaceuticals, For: Nov 17
11/19
09:08 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Keyes Jeffry R.
Medium
Report
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Keyes Jeffry R.
11/19
05:00 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Mahery Amy
Medium
Report
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Mahery Amy
11/19
05:00 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Downs Christopher
Medium
Report
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Downs Christopher
11/19
05:00 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Climaco John M
Medium
Report
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Climaco John M
11/19
05:00 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Charles Faith L.
Medium
Report
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Charles Faith L.
11/19
05:00 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Gumulka Jerzy
Medium
Report
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Gumulka Jerzy
11/19
05:00 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Cockroft Bettina M.
Medium
Report
Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Cockroft Bettina M.
11/14
06:40 pm
cnsp
Form SCHEDULE 13G/A CNS Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
Medium
Report
Form SCHEDULE 13G/A CNS Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
11/14
05:11 pm
cnsp
Form 10-Q CNS Pharmaceuticals, For: Sep 30
Low
Report
Form 10-Q CNS Pharmaceuticals, For: Sep 30
11/12
05:00 pm
cnsp
Form DEFA14A CNS Pharmaceuticals,
Low
Report
Form DEFA14A CNS Pharmaceuticals,